Cross-source evidence timeline
Difelikefalin research timeline
Follow 24 selected, directly cited source records from January 27, 2020 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
New Drugs Update: Finerenone, Difelikefalin, and Avacopan.↗
PubMed lists PMID 35337427 in The Senior care pharmacist as Journal Article, with publication-date metadata of 2022-04-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 1, 2022 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT06593392↗
PeptideScanner retained ClinicalTrials.gov record NCT06593392 at 2026-11-15T21:56:33.343Z. Its registry update date was 2026-10-23, and PeptideScanner's reviewed identity mapping was difelikefalin.↗
Added to PeptideScanner November 15, 2026Regulatory
Drugs@FDA application ANDA220919↗
The official Drugs@FDA dataset lists original submission 1 for ANDA 220919 with status AP dated 2026-08-31, and names difelikefalin acetate among the application record's active ingredients.↗
Added to PeptideScanner November 15, 2026Literature metadata
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2.↗
PubMed lists PMID 38253036 in American journal of nephrology as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-01-22 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 22, 2024 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.↗
PubMed lists PMID 31702883 in The New England journal of medicine as Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, and 1 more PubMed publication type, with publication-date metadata of 2019-11-08 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 8, 2019 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.↗
PubMed lists PMID 36780675 in The New England journal of medicine as Randomized Controlled Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-02-09 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 9, 2023 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin Studies.↗
PubMed lists PMID 39037824 in Kidney360 as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07-22 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 22, 2024 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2025
Literature metadata
Difelikefalin for Hemodialysis Patients with Pruritus in Japan.↗
PubMed lists PMID 38320524 in NEJM evidence as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-17 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 17, 2023 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Difelikefalin in the treatment of hemodialysis patients with pruritus: a systematic review and meta-analysis.↗
PubMed lists PMID 39712488 in Frontiers in pharmacology as Journal Article, Systematic Review, with publication-date metadata of 2024-12-06 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 6, 2024 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2024
Clinical trials
ClinicalTrials.gov record NCT03617536↗
PeptideScanner retained ClinicalTrials.gov record NCT03617536 at 2026-11-15T21:56:33.343Z. Its registry update date was 2024-01-24, and PeptideScanner's reviewed identity mapping was difelikefalin.↗
Added to PeptideScanner November 15, 2026
Source year
2023
Regulatory
Federal Register notice 2023-26106↗
The Federal Register published notice 2023-26106, attributed to FDA and its parent HHS department, on 2023-11-28. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; Korsuva,” and PeptideScanner's exact reviewed identity mapping connects the document to Difelikefalin.↗
Added to PeptideScanner November 15, 2026Literature metadata
Difelikefalin in Hemodialysis Patients with Pruritus.↗
PubMed lists PMID 32433845 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 21, 2020 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Difelikefalin in Hemodialysis Patients with Pruritus.↗
PubMed lists PMID 32433846 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 21, 2020 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Difelikefalin in Hemodialysis Patients with Pruritus.↗
PubMed lists PMID 32433847 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 21, 2020 · day precisionAdded to PeptideScanner November 15, 2026Regulatory
Federal Register notice 2023-10710↗
The Federal Register published notice 2023-10710, attributed to FDA and its parent HHS department, on 2023-05-19. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Difelikefalin.↗
Added to PeptideScanner November 15, 2026
Source year
2022
Clinical trials
ClinicalTrials.gov record NCT05533008↗
PeptideScanner retained ClinicalTrials.gov record NCT05533008 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-09-08, and PeptideScanner's reviewed identity mapping was difelikefalin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03422653↗
PeptideScanner retained ClinicalTrials.gov record NCT03422653 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03636269↗
PeptideScanner retained ClinicalTrials.gov record NCT03636269 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.↗
Added to PeptideScanner November 15, 2026
Source year
2021
Literature metadata
Difelikefalin Acetate.↗
PubMed lists PMID 34849553 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-01-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 1, 2022 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03998163↗
PeptideScanner retained ClinicalTrials.gov record NCT03998163 at 2026-11-15T21:56:33.343Z. Its registry update date was 2021-10-15, and PeptideScanner's reviewed identity mapping was difelikefalin.↗
Added to PeptideScanner November 15, 2026Regulatory
Drugs@FDA application NDA214916↗
The official Drugs@FDA dataset lists original submission 1 for NDA 214916 with status AP dated 2021-08-23, and names difelikefalin acetate among the application record's active ingredients.↗
Added to PeptideScanner November 15, 2026Literature metadata
An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease.↗
PubMed lists PMID 33190563 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2020-12-14 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 14, 2020 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2020
Literature metadata
Difelikefalin in Hemodialysis Patients with Pruritus. Reply.↗
PubMed lists PMID 32433848 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 21, 2020 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Difelikefalin for the Treatment of Uremic Pruritus.↗
PubMed lists PMID 31940704 in The New England journal of medicine as Editorial, Comment, with publication-date metadata of 2020-01-16 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 16, 2020 · day precisionAdded to PeptideScanner November 15, 2026